SEB Asset Management’s Oruka Therapeutics ORKA Stock Holding History

SEB Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7M	Buy	+196,753	New	+$13.1M	0.07%	232

Other funds holding ORKA

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SAM

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SEB Asset Management's ORKA Position: Q2 2026 in Review

SEB Asset Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 196,753 shares worth $18.7M. The stake represents 0.07% of the portfolio and ranks #232 among its holdings.

49 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

SEB Asset Management held 196,753 shares of Oruka Therapeutics worth $18.7M as of Q2 2026.
Oruka Therapeutics was a new SEB Asset Management position in Q2 2026.
Oruka Therapeutics made up 0.07% of SEB Asset Management's portfolio in Q2 2026, its #232 holding.
49 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.